{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:49Z","timestamp":1772120029493,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clinre.2020.05.011","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T17:15:54Z","timestamp":1592586954000},"page":"101463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT"],"prefix":"10.1016","volume":"45","author":[{"given":"Zhao","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinre.2020.05.011_bib0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","author":"Razavi-Shearer","year":"2018","journal-title":"The Lancet Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2020.05.011_bib0160","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2020.05.011_bib0165","doi-asserted-by":"crossref","first-page":"f3893","DOI":"10.1136\/bmj.f3893","article-title":"Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance","volume":"346","author":"Sarri","year":"2013","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.clinre.2020.05.011_bib0170","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MCG.0000000000000544","article-title":"Histologic Disease in Chinese Chronic Hepatitis B Patients With Low Viral Loads and Persistently Normal Alanine Aminotransferase Levels","volume":"50","author":"Wang","year":"2016","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"10.1016\/j.clinre.2020.05.011_bib0175","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2020.05.011_bib0180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2020.05.011_bib0185","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2020.05.011_bib0190","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12072-015-9681-6","article-title":"Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment","volume":"10","author":"Kozielewicz","year":"2015","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.clinre.2020.05.011_bib0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jvh.12034","article-title":"Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels","volume":"20","author":"Du","year":"2013","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"10.1016\/j.clinre.2020.05.011_bib0200","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1002\/jcb.27959","article-title":"Management of individuals with chronic hepatitis B virus infection and persistent normal or mildly elevated aminotransferase levels","volume":"120","author":"Yan","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"issue":"7","key":"10.1016\/j.clinre.2020.05.011_bib0205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/jvh.12679","article-title":"Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels","volume":"24","author":"Chen","year":"2017","journal-title":"Journal of Viral Hepatitis"},{"issue":"29","key":"10.1016\/j.clinre.2020.05.011_bib0210","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/MD.0000000000000322","article-title":"Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study","volume":"93","author":"Jia","year":"2014","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.clinre.2020.05.011_bib0215","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1128\/CVI.00457-09","article-title":"Novel double-antigen sandwich immunoassay for human hepatitis B core antibody","volume":"17","author":"Li","year":"2010","journal-title":"Clinical and vaccine immunology"},{"issue":"7","key":"10.1016\/j.clinre.2020.05.011_bib0220","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1111\/liv.12344","article-title":"A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase\u22642 upper limit of normal","volume":"34","author":"Gao","year":"2014","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinre.2020.05.011_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jgh.13452","article-title":"A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase\u22642upper limit of normal","volume":"32","author":"Gao","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2020.05.011_bib0230","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/jvh.13030","article-title":"Clinical noninvasive markers for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase less than two times upper limit of normal","volume":"26","author":"Wu","year":"2019","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.clinre.2020.05.011_bib0235","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2020.05.011_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatology International"},{"issue":"4","key":"10.1016\/j.clinre.2020.05.011_bib0245","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2020.05.011_bib0250","doi-asserted-by":"crossref","first-page":"e0134532","DOI":"10.1371\/journal.pone.0134532","article-title":"A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B","volume":"10","author":"Gong","year":"2015","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.clinre.2020.05.011_bib0255","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3748\/wjg.v23.i15.2802","article-title":"Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients","volume":"23","author":"Cheng","year":"2017","journal-title":"World Journal of Gastroenterology"},{"issue":"124","key":"10.1016\/j.clinre.2020.05.011_bib0260","first-page":"19","article-title":"The independent predictors of significant liver histological changes in chronic hepatitis B virus infection patients with persistently high-normal or low-normal alanine transaminase levels","volume":"23","author":"Li","year":"2017","journal-title":"Discov Med"},{"key":"10.1016\/j.clinre.2020.05.011_bib0265","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2016.09.007","article-title":"Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels","volume":"52","author":"Ormeci","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.clinre.2020.05.011_bib0270","doi-asserted-by":"crossref","first-page":"e80585","DOI":"10.1371\/journal.pone.0080585","article-title":"Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.clinre.2020.05.011_bib0275","doi-asserted-by":"crossref","first-page":"E133","DOI":"10.1111\/hepr.12937","article-title":"Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels","volume":"48","author":"Li","year":"2018","journal-title":"Hepatol Res"},{"issue":"9","key":"10.1016\/j.clinre.2020.05.011_bib0280","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1478-3231.2011.02570.x","article-title":"Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels","volume":"31","author":"Cheong","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2020.05.011_bib0285","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41598-018-23646-2","article-title":"Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels","author":"Li","year":"2018","journal-title":"Scientific reports"},{"issue":"5","key":"10.1016\/j.clinre.2020.05.011_bib0290","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","article-title":"High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B","volume":"67","author":"Kim","year":"2018","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.clinre.2020.05.011_bib0295","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/infdis\/jix506","article-title":"Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study","volume":"216","author":"Chang","year":"2017","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.clinre.2020.05.011_bib0300","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1007\/s10620-015-4027-8","article-title":"Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France","volume":"61","author":"Marcellin","year":"2016","journal-title":"Dig Dis Sci"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012030156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012030156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:29:42Z","timestamp":1761895782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221074012030156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S221074012030156X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2020.05.011","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2020.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101463"}}